Immune checkpoint inhibitors: therapeutic advances in melanoma

Autor Márquez-Rodas, Ivan, Cerezuela, Pablo, Soria, Ainara, Berrocal, Alfonso, Riso, Aldo, González-Cao, María, Martín-Algarra, Salvador
Vydáno v Ann Transl Med (2015)

Predictive factors of response to immunotherapy—a review from the Spanish Melanoma Group (GEM)

Autor Espinosa, Enrique, Márquez-Rodas, Ivan, Soria, Ainara, Berrocal, Alfonso, Manzano, Jose Luis, Gonzalez-Cao, Maria, Martin-Algarra, Salvador
Vydáno v Ann Transl Med (2017)

Highlights of the season 2016–2017 by the Spanish Melanoma Group (GEM)

Autor Soria, Ainara, Manzano, Jose Luis, Berrocal, Alfonso, Espinosa, Enrique, Marquez-Rodas, Ivan, Gonzalez-Cao, Maria, Martin-Algarra, Salvador
Vydáno v Ann Transl Med (2017)

Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene

Autor Tanic, Miljana, Yanowsky, Kira, Rodriguez-Antona, Cristina, Andrés, Raquel, Márquez-Rodas, Iván, Osorio, Ana, Benitez, Javier, Martinez-Delgado, Beatriz
Vydáno 2012

Simultaneous diagnosis of liver PEComa in a family with known Li–Fraumeni syndrome: a case report

Autor Galera López, María del Mar, Márquez Rodas, Iván, Agra Pujol, Carolina, García Pérez, Ángela, Velasco Sánchez, Enrique, Álvarez Álvarez, Rosa
Vydáno v Clin Sarcoma Res (2020)

Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

Autor Garcia‐Carbonero, Rocio, Marquez‐Rodas, Ivan, de la Cruz‐Merino, Luis, Martinez‐Trufero, Javier, Cabrera, Miguel Angel, Piulats, Jose Maria, Capdevila, Jaume, Grande, Enrique, Martin‐Algarra, Salvador, Berrocal, Alfonso
Vydáno v Oncologist (2019)

The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study

Autor Ascierto, Paolo A., Bastholt, Lars, Ferrucci, Pier F., Hansson, Johan, Márquez Rodas, Iván, Payne, Miranda, Robert, Caroline, Thomas, Luc, Utikal, Jochen S., Wolter, Pascal, Kudlac, Amber, Tuson, Harriet, McKendrick, Jan
Vydáno v Melanoma Res (2018)

Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical Trials

Autor Long, Georgina V., Weber, Jeffrey S., Larkin, James, Atkinson, Victoria, Grob, Jean-Jacques, Schadendorf, Dirk, Dummer, Reinhard, Robert, Caroline, Márquez-Rodas, Ivan, McNeil, Catriona, Schmidt, Henrik, Briscoe, Karen, Baurain, Jean-François, Hodi, F. Stephen, Wolchok, Jedd D.
Vydáno v JAMA Oncol (2017)

Melanoma proteomics suggests functional differences related to mutational status

Autor Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Prado-Vázquez, Guillermo, Zapater-Moros, Andrea, Díaz-Almirón, Mariana, Fortes, Claudia, Ferrer-Gómez, María, López-Vacas, Rocío, Parra Blanco, Verónica, Márquez-Rodas, Iván, Soria, Ainara, Fresno Vara, Juan Ángel, Espinosa, Enrique
Vydáno v Sci Rep (2019)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C

Autor Aznar, M. Angela, Planelles, Lourdes, Perez-Olivares, Mercedes, Molina, Carmen, Garasa, Saray, Etxeberría, Iñaki, Perez, Guiomar, Rodriguez, Inmaculada, Bolaños, Elixabet, Lopez-Casas, Pedro, Rodriguez-Ruiz, Maria E., Perez-Gracia, Jose L., Marquez-Rodas, Ivan, Teijeira, Alvaro, Quintero, Marisol, Melero, Ignacio
Vydáno v J Immunother Cancer (2019)

Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial

Autor Lebbé, Celeste, Meyer, Nicolas, Mortier, Laurent, Marquez-Rodas, Ivan, Robert, Caroline, Rutkowski, Piotr, Menzies, Alexander M., Eigentler, Thomas, Ascierto, Paolo A., Smylie, Michael, Schadendorf, Dirk, Ajaz, Mazhar, Svane, Inge Marie, Gonzalez, Rene, Rollin, Linda, Lord-Bessen, Jennifer, Saci, Abdel, Grigoryeva, Elena, Pigozzo, Jacopo
Vydáno v J Clin Oncol (2019)

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

Autor Martín, Miguel, Custodio, Sara, de las Casas, Maria-Luisa Maestro, García-Sáenz, José-Ángel, de la Torre, Julio-César, Bellón-Cano, Jose-María, López-Tarruella, Sara, Vidaurreta-Lazaro, Marta, de la Orden, Virginia, Jerez, Yolanda, Márquez-Rodas, Iván, Casado, Antonio, Sastre, Javier, Díaz-Rubio, Eduardo
Vydáno 2013

Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)

Autor Gonzalez-Cao, Maria, Puertolas, Teresa, Riveiro, Mar, Muñoz-Couselo, Eva, Ortiz, Carolina, Paredes, Roger, Podzamczer, Daniel, Manzano, Jose Luis, Molto, Jose, Revollo, Boris, Carrera, Cristina, Mateu, Lourdes, Fancelli, Sara, Espinosa, Enrique, Clotet, Bonaventura, Martinez-Picado, Javier, Cerezuela, Pablo, Soria, Ainara, Marquez-Rodas, Ivan, Mandala, Mario, Berrocal, Alfonso
Vydáno v J Immunother Cancer (2021)

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Autor Karachaliou, Niki, Gonzalez-Cao, Maria, Crespo, Guillermo, Drozdowskyj, Ana, Aldeguer, Erika, Gimenez-Capitan, Ana, Teixido, Cristina, Molina-Vila, Miguel Angel, Viteri, Santiago, De Los Llanos Gil, Maria, Algarra, Salvador Martin, Perez-Ruiz, Elisabeth, Marquez-Rodas, Ivan, Rodriguez-Abreu, Delvys, Blanco, Remedios, Puertolas, Teresa, Royo, Maria Angeles, Rosell, Rafael
Vydáno v Ther Adv Med Oncol (2018)

Dabrafenib plus trametinib in patients with BRAF V600–mutant melanoma brain metastases (COMBI-MB): a multi-cohort, open-label, phase 2 trial

Autor Davies, Michael A, Saiag, Philippe, Robert, Caroline, Grob, Jean-Jacques, Flaherty, Keith T, Arance, Ana, Chiarion-Sileni, Vanna, Thomas, Luc, Lesimple, Thierry, Mortier, Prof Laurent, Moschos, Stergios J, Hogg, David, Márquez-Rodas, Iván, Del Vecchio, Michele, Lebbé, Céleste, Meyer, Nicolas, Zhang, Ying, Huang, Yingjie, Mookerjee, Bijoyesh, Long, Georgina V
Vydáno v Lancet Oncol (2017)

Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis

Autor D’Angelo, Sandra P., Larkin, James, Sosman, Jeffrey A., Lebbé, Celeste, Brady, Benjamin, Neyns, Bart, Schmidt, Henrik, Hassel, Jessica C., Hodi, F. Stephen, Lorigan, Paul, Savage, Kerry J., Miller, Wilson H., Mohr, Peter, Marquez-Rodas, Ivan, Charles, Julie, Kaatz, Martin, Sznol, Mario, Weber, Jeffrey S., Shoushtari, Alexander N., Ruisi, Mary, Jiang, Joel, Wolchok, Jedd D.
Vydáno v J Clin Oncol (2017)

Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification

Autor Echavarria, Isabel, López-Tarruella, Sara, Picornell, Antoni, García-Saenz, Jose Ángel, Yolanda Jerez, Y, Hoadley, Katherine, Gómez, Henry L, Moreno, Fernando, Del Monte-Millan, María, Márquez-Rodas, Iván, Alvarez, Enrique, Ramos-Medina, Rocío, Gayarre, Javier, Massarrah, Tatiana, Ocaña, Inmaculada, Cebollero, María, Fuentes, Hugo, Barnadas, Agusti, Ballesteros, Ana Isabel, Bohn, Uriel, Perou, Charles M, Martin, Miguel
Vydáno v Clin Cancer Res (2018)

Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study

Autor Márquez-Rodas, Iván, Pollán, Marina, Escudero, María José, Ruiz, Amparo, Martín, Miguel, Santaballa, Ana, Martínez del Prado, Purificación, Batista, Norberto, Andrés, Raquel, Antón, Antonio, Llombart, Antonio, Fernandez Aramburu, Antonio, Adrover, Encarnación, González, Sonia, Seguí, Miguel Angel, Calvo, Lourdes, Lizón, José, Rodríguez Lescure, Álvaro, Ramón y Cajal, Teresa, Llort, Gemma, Jara, Carlos, Carrasco, Eva, López-Tarruella, Sara
Vydáno v PLoS One (2017)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

Autor Martin, Miguel, Ramos-Medina, Rocio, Bernat, Rebeca, García-Saenz, Jose Angel, del Monte-Millan, Maria, Alvarez, Enrique, Cebollero, Maria, Moreno, Fernando, Gonzalez-Haba, Eva, Bueno, Oscar, Romero, Paula, Massarrah, Tatiana, Echavarria, Isabel, Jerez, Yolanda, Herrero, Blanca, Gonzalez del Val, Ricardo, Lobato, Nerea, Rincon, Patricia, Palomero, Maria Isabel, Marquez-Rodas, Ivan, Lizarraga, Santiago, Asensio, Fernando, Lopez-Tarruella, Sara
Vydáno v Sci Rep (2021)

Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Español Multidisciplinar de Melanoma – Prima study

Autor Espinosa, Enrique, Soriano, Virtudes, Malvehy, Josep, Berrocal, Alfonso, Martínez de Prado, Purificación, Quindós, María, Soria, Ainara, Márquez-Rodas, Iván, Palacio, Isabel, Cerezuela, Pablo, López-Vivanco, Guillermo, Alonso, Lorenzo, Samaniego, Elia, Ballesteros, Ana, Puértolas, Teresa, Díaz-Beveridge, Rodrigo, de la Cruz-Merino, Luis, López Castro, Rafael, López López, Rafael, Stevinson, Kendall, del Barrio, Patricia, Tornamira, Maria V., Guillém, Vicente, Martín-Algarra, Salvador
Vydáno v Melanoma Res (2016)